Inowell Pharma Private Limited

Inowell Pharma Private Limited - healthcare in Indore, Madhya Pradesh, India. FY 2026 financials & compliance.
CIN U24239MP2018PTC046364 Incorporated 16 August 2018 ROC Gwalior HQ Indore, Madhya Pradesh, India
Active Private Limited Company healthcare MSME · Micro
Revenue · FY 2025
₹1.55 Cr
▲ 33% YoY
Net profit · FY 2025
₹79,134
Net margin 0.5%
EBITDA · FY 2025
₹10.7 Lakh
EBITDA margin 6.9%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.97 Lakh
Secured borrowings
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings

About Inowell Pharma Private Limited

Data last updated:

Inowell Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the preventive healthcare segment of the healthcare sector. It was incorporated on 16 August 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24239MP2018PTC046364. Its GSTIN is 23AAECI9612H1ZO (Madhya Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rani Tanwar and Ritu Chouhan.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 198/A Swasth Nagar, Indore, Madhya Pradesh, India – 452010.

As per the financials filed for FY 2025, the company reported a revenue of ₹1.55 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹79,134 (net margin 0.5%) and EBITDA of ₹10.7 Lakh (EBITDA margin 6.9%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 35% over five years.

As per MCA filings, the company has open charges of ₹8.97 Lakh on record.

Inowell Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-23-0068540).

Company details

CIN U24239MP2018PTC046364
Registration Number 046364
Incorporation Date 16 August 2018
ROC Gwalior
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-MP-23-0068540

Recognitions & Rankings of Inowell Pharma

MSME (Udyam registered) Ministry of MSME
Category
Micro (2024-25)
Udyam number
UDYAM-MP-23-0068540

Contact details

Inowell Pharma Private Limited's registered office is in Indore, Madhya Pradesh. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    198/A Swasth Nagar, Indore, Madhya Pradesh, India – 452010
  • Industry
    Healthcare, Preventive Health Services

To see the full contact details of Inowell Pharma Private Limited, buy the company report.

Comprehensive company report
Inowell Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Inowell Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Inowell Pharma Private Limited, buy the company report.

Financials of Inowell Pharma Private Limited

FY 2025 filings available

Inowell Pharma Private Limited reported revenue of ₹1.55 Cr (up 33% YoY) for FY 2025.

Revenue · FY 2025
₹1.55 Cr ▲ 33%
Net profit · FY 2025
₹79,134 margin 0.5%
EBITDA · FY 2025
₹10.7 Lakh margin 6.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 24%
5 years · compounded
▲ 35%
EBITDA CAGR growth
3 years · compounded
▲ 46%
5 years · compounded
▲ 62%

Revenue has grown at a compounded annual rate (CAGR) of 35% over five years, including 33% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹10.7 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹79,134
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin6.9%
Net Profit Margin0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Inowell Pharma Private Limited, buy the company report.

Board of directors of Inowell Pharma Private Limited

Inowell Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rani TanwarDirector04 May 20224 Years 6 MonthsCurrent
Ritu ChouhanDirector04 May 20224 Years 6 MonthsCurrent

Auditor

Inowell Pharma Private Limited is audited by A R H & CO for the financial year 2023.

Auditor firmFinancial yearFirm registration number
A R H & COFY 2023140929W

Shareholding

The shareholding of Inowell Pharma Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Inowell Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹8.97 Lakh
Satisfied charges
None
Breakdown by lending institutions
Hdfc Bank Limited₹0.09 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
15 Dec 2022100674654Hdfc Bank Limited₹8.97 LakhOpen

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Inowell Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Inowell Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAECI9612H1ZOMadhya PradeshActive08 Oct 2018

To see the full GST registrations and return filing status of Inowell Pharma Private Limited, buy the company report.

Recent activity

Inowell Pharma Private Limited has 4 board changes on record since 2022: 2 appointments and 2 cessations. The latest: Jaypal Singh Tanwar ceased to be Director on 20 May 2022.

AGM
Inowell Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Inowell Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 8.97 Lakh with Charge ID 100674654 was registered on 15 Dec 2022.
Ceased
Jaypal Singh Tanwar ceased to be Director.
Ceased
Rupendra Singh Chouhan ceased to be Director.
Appointed
Rani Tanwar was appointed as Director.
Appointed
Ritu Chouhan was appointed as Director.
Incorporation
16 Aug 2018
Inowell Pharma Private Limited was registered on 16 Aug 2018 with Roc Gwalior & aged 8 years 3 months as per MCA records.

Frequently asked questions

Inowell Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in preventive health services, within the healthcare industry. It was incorporated on 16 August 2018 (8+ years old) and is registered under CIN U24239MP2018PTC046364.

Inowell Pharma has 2 current directors:

The latest financial statements of Inowell Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Inowell Pharma is 23AAECI9612H1ZO, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Inowell Pharma is U24239MP2018PTC046364. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Inowell Pharma was incorporated on 16 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Gwalior.

Jaypal Singh Tanwar ceased to be Director on 20 May 2022. Rupendra Singh Chouhan ceased to be Director on 20 May 2022. Rani Tanwar was appointed as Director on 04 May 2022. Inowell Pharma has 4 board changes on record in total.

Yes, Inowell Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-23-0068540).

The registered office of Inowell Pharma is at 198A Swasth Nagar, Indore, Madhya Pradesh, India – 452010.

Inowell Pharma operates in the healthcare industry, in the preventive health services segment.